Liver Fibrosis and Inflammation under the Control of ERK2

Liver Fibrosis and Inflammation under the Control of ERK2

Chronic liver injury could lead the formation of liver fibrosis, eventually some would develop to hepatocellular carcinoma (HCC), one of the leading malignancies worldwide. The aim of the study is to dissect the role of extracellular signal-regulated kinase 2 (ERK2) signaling in liver fibrosis and i...

Full description

Bibliographic Details
Main Authors:	Kuo-Shyang Jeng, Ssu-Jung Lu, Chih-Hsuan Wang, Chiung-Fang Chang
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	International Journal of Molecular Sciences
Subjects:	ERK2 MAPK liver cirrhosis liver inflammation
Online Access:	https://www.mdpi.com/1422-0067/21/11/3796

Similar Items

Schizandrin C regulates lipid metabolism and inflammation in liver fibrosis by NF-κB and p38/ERK MAPK signaling pathways
by: Panpan Chen, et al.
Published: (2023-05-01)

Upper Gastrointestinal Cancer and Liver Cirrhosis
by: Kuo-Shyang Jeng, et al.
Published: (2022-05-01)

Saffron reduces the liver fibrosis in mice by inhibiting the JAK/STAT3 pathway
by: Lijuan Huang, et al.
Published: (2023-12-01)

Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches
by: Indu Rajapaksha
Published: (2022-11-01)

MAPK/ERK Pathway as a Central Regulator in Vertebrate Organ Regeneration
by: Xiaomin Wen, et al.
Published: (2022-01-01)

Expression and Correlation of MIF and ERK1/2 in Liver Cirrhosis and Hepatocellular Carcinoma Induced by Hepatitis B
by: Jia D, et al.
Published: (2023-04-01)

A review of liver fibrosis and cirrhosis regression
by: Michael J. Lee
Published: (2023-07-01)

Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression
by: Magdalena Śmiech, et al.
Published: (2022-01-01)

Impact of Liver Fibrosis Severity on Oncological Prognosis in Hepatocellular Carcinoma
by: Koya Yasukawa, et al.
Published: (2023-10-01)

Complex Cell Type-Specific Roles of Autophagy in Liver Fibrosis and Cirrhosis
by: Tzu-Min Hung, et al.
Published: (2020-03-01)

Involvement of the ERK MAPK Cascade in the Formation of Adhesions in the Abdominal Cavity
by: I. A. Shurygina, et al.
Published: (2021-01-01)

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis
by: Li-ya Mu, et al.
Published: (2021-06-01)

The Survival of Septic Patients with Compensated Liver Cirrhosis Is Not Inferior to That of Septic Patients without Liver Cirrhosis: A Propensity Score Matching Analysis
by: Ya-Chun Chang, et al.
Published: (2022-03-01)

Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension
by: Eric Kalo, et al.
Published: (2021-09-01)

Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
by: Tomoko Tadokoro, et al.
Published: (2021-07-01)

Diagnostic Accuracy of Indocyanine Green Clearance Test for Different Stages of Liver Fibrosis and Cirrhosis
by: Lukas Luerken, et al.
Published: (2023-08-01)

CHANGES IN FIBROSIS UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADEMETHYANINIUM AND ARGININE GLUTAMATE
by: N.R. Matkovska
Published: (2020-11-01)

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
by: Isabel Graupera, et al.
Published: (2022-07-01)

Thrombocytopenia (TCP), MELD Score, and Fibrosis Index (FI) Among Hospitalized Patients with Chronic Liver Disease (CLD) in Ma’abar City, Dhamar Governorate, Yemen: A Cross-Sectional Study
by: Al-Dholae MHH, et al.
Published: (2023-04-01)

Non Invasive Assessment of Fibrosis in Non Alcoholic Fatty Liver Disease by Shear Wave Elastography and NAFLD Fibrosis Score: A Cross-sectional Study
by: BN Vinyasa, et al.
Published: (2022-08-01)

Improving the Effect of Ferulic Acid on Inflammation and Insulin Resistance by Regulating the JNK/ERK and NF-κB Pathways in TNF-α-Treated 3T3-L1 Adipocytes
by: Jae-Eun Park, et al.
Published: (2024-01-01)

Approach to Liver Transplantation: Is There a Difference between East and West?
by: Nazli Begum Ozturk, et al.
Published: (2024-03-01)

Transjugular Liver Biopsy: Results of 97 Patients
by: Kemal Deniz, et al.
Published: (2012-06-01)

TPI1 promotes MAPK/ERK‐induced EMT, cell migration and invasion in lung adenocarcinoma
by: Yu Li, et al.
Published: (2024-02-01)

Role of radiomics in staging liver fibrosis: a meta-analysis
by: Xiao-min Wang, et al.
Published: (2024-04-01)

From NAFLD to Chronic Liver Diseases. Assessment of Liver Fibrosis through Non-Invasive Methods before Liver Transplantation: Can We Rely on Them?
by: Pasquale Auricchio, et al.
Published: (2023-05-01)

Formyl Peptide Receptor 2 Alleviates Hepatic Fibrosis in Liver Cirrhosis by Vascular Remodeling
by: Ji Hye Jun, et al.
Published: (2021-02-01)

Serum kallistatin as a marker of severity of liver fibrosis in cirrhosis: A cross-sectional observational study
by: Seetaram Singh Kularaj, et al.
Published: (2022-01-01)

Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis
by: Thanaput Kunlayawutipong, et al.
Published: (2024-03-01)

Acute-On-Chronic Liver Failure: Current Interventional Treatment Options and Future Challenges
by: Markus Kimmann, et al.
Published: (2023-06-01)

The Modulation of Phospho-Extracellular Signal-Regulated Kinase and Phospho-Protein Kinase B Signaling Pathways plus Activity of Macrophage-Stimulating Protein Contribute to the Protective Effect of Stachydrine on Acetaminophen-Induced Liver Injury
by: Fu-Chao Liu, et al.
Published: (2024-01-01)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
by: Hwi Seung Kim, et al.
Published: (2023-01-01)

Research on the oxidized dextran effect on fibrosis in the liver of rats with toxic hepatosis and liver cirrhosis
by: M. A. Karpov, et al.
Published: (2022-02-01)

ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2/ERK signaling pathways
by: Zongli Zhang, et al.
Published: (2023-05-01)

Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study
by: Yoonseok Lee, et al.
Published: (2023-01-01)

Clinical impact of the Model for End Liver Disease (MELD) score on the presence of microvascular invasion and on the postoperative outcome in patients undergoing liver transplantation
by: BRAINNER CAMPOS BARBOSA, et al.
Published: (2021-12-01)

Noninvasive Assessment of Liver Fibrosis by Magnetic Resonance Elastography in Patients with Rheumatic Disease on Long-Term Methotrexate Treatment
by: Arindam Nandy Roy, et al.
Published: (2023-01-01)

PROGNOSTIC FACTORS OF LIVER TRANSPLANTATION FOR ACUTE-ON-CHRONIC LIVER FAILURE
by: Jane CRONST, et al.
Published: (2023-12-01)

THE EXPERIENCE OF WAITING LIST MANAGEMENT FOR LIVER TRANSPLANTATION IN EKATERINBURG
by: E. N. Bessonova, et al.
Published: (2011-12-01)

Editorial: Portal hypertension in cirrhosis and liver vascular diseases: from ethiopathogenesis to current strategies
by: Xuefeng Luo, et al.
Published: (2023-09-01)